China Pharma Holdings, Inc. (CPHI)
NYSEAMERICAN: CPHI · Real-Time Price · USD
2.251
+0.136 (6.43%)
At close: May 12, 2025, 4:00 PM
2.251
0.00 (0.00%)
After-hours: May 12, 2025, 6:30 PM EDT
China Pharma Holdings Market Cap
China Pharma Holdings has a market cap or net worth of $7.34 million as of May 12, 2025. Its market cap has increased by 56.22% in one year.
Market Cap
7.34M
Enterprise Value
9.86M
1-Year Change
56.22%
Ranking
Category
Stock Price
$2.25
Market Cap Chart
Since May 16, 2002, China Pharma Holdings's market cap has decreased from $526.80M to $7.34M, a decrease of -98.61%. That is a compound annual growth rate of -16.96%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 9, 2025 | 6.90M | 53.33% |
Dec 31, 2024 | 4.50M | 12.50% |
Dec 29, 2023 | 4.00M | -20.00% |
Dec 30, 2022 | 5.00M | -78.07% |
Dec 31, 2021 | 22.80M | 17.53% |
Dec 31, 2020 | 19.40M | 88.35% |
Dec 31, 2019 | 10.30M | -8.04% |
Dec 31, 2018 | 11.20M | 45.45% |
Dec 29, 2017 | 7.70M | -31.86% |
Dec 30, 2016 | 11.30M | 66.18% |
Dec 31, 2015 | 6.80M | -48.09% |
Dec 31, 2014 | 13.10M | -12.67% |
Dec 31, 2013 | 15.00M | 70.45% |
Dec 31, 2012 | 8.80M | -69.86% |
Dec 30, 2011 | 29.20M | -77.79% |
Dec 31, 2010 | 131.50M | -19.23% |
Dec 31, 2009 | 162.80M | 237.76% |
Dec 31, 2008 | 48.20M | -99.18% |
Dec 29, 2006 | 5.86B | 26.11% |
Dec 30, 2005 | 4.65B | 22,353.14% |
Dec 31, 2004 | 20.70M | -86.64% |
Dec 31, 2003 | 154.90M | 25.02% |
Dec 31, 2002 | 123.90M | -76.48% |
View and export this data all the way back to 2002.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 659.45B |
Johnson & Johnson | 371.06B |
UnitedHealth Group | 345.29B |
AbbVie | 326.55B |
Novo Nordisk | 297.79B |
Abbott Laboratories | 231.82B |
Novartis AG | 214.71B |
AstraZeneca | 211.14B |